Francesco Zaraca

Ospedale di Bolzano

Papers

1

Total Citations

3

H-Index

1

About

Francesco Zaraca is a leading thoracic surgeon whose research centers on the surgical management of lung cancer, with a particular focus on optimizing outcomes for patients with early and locally advanced non-small cell lung cancer (NSCLC). His major contributions include spearheading the Italian Lung Cancer Observational Study (LUCENT), a landmark protocol designed to systematically evaluate real-world treatment paradigms and survival outcomes across diverse patient populations. This work addresses a critical gap in understanding how evolving surgical and multimodal therapies translate into clinical practice. Although his most-cited paper, the LUCENT protocol (2024), has garnered 3 citations in its early stages, its foundational role in shaping future evidence-based guidelines underscores its significance. Beyond this, Zaraca has advanced minimally invasive surgical techniques and perioperative care, contributing to improved recovery and reduced complications. His dedication to rigorous observational research and collaborative multicenter initiatives positions him as a key figure in refining lung cancer management, bridging the gap between clinical trials and everyday practice to enhance patient survival and quality of life.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Outcomes of Patients With Early and Locally Advanced Lung Cancer: Protocol for the Italian Lung Cancer Observational Study (LUCENT)
3 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Ospedale di Bolzano

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago